Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Mucin type O-glycan biosynthesis,5/36,0.0095920111719752,0.999994989965232,0,0,4.261786600496278,19.803775226567584,GALNT12;GALNT7;GALNT15;GALNT17;ST6GALNAC3
KEGG_2021_Human,Fatty acid elongation,4/27,0.0160569201818582,0.999994989965232,0,0,4.590922645673048,18.967926511868228,ELOVL2;PPT1;THEM4;ELOVL6
KEGG_2021_Human,Other types of O-glycan biosynthesis,5/47,0.0281419313334648,0.999994989965232,0,0,3.143805599162742,11.224940904637442,GALNT12;GALNT7;GALNT15;GALNT17;RFNG
KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,3/26,0.0682525276029421,0.999994989965232,0,0,3.438475282906492,9.2307272250156,PIGQ;MPPE1;PIGH
KEGG_2021_Human,Hippo signaling pathway,10/163,0.0774717408837257,0.999994989965232,0,0,1.7279129263508075,4.419728329449458,RASSF2;TGFB1;WNT5A;TCF7;CTNNA1;FZD8;SCRIB;LLGL1;TEAD2;TGFBR1
KEGG_2021_Human,Pancreatic secretion,7/102,0.080884628584175,0.999994989965232,0,0,1.945831520951138,4.893243776836318,CPA1;CLCA2;SCTR;ITPR2;CD38;PRSS3;SLC26A3
KEGG_2021_Human,Glyoxylate and dicarboxylate metabolism,3/30,0.0958988115527792,0.999994989965232,0,0,2.928462709284627,6.865668631741249,ACSS2;GLYCTK;ACO1
KEGG_2021_Human,beta-Alanine metabolism,3/30,0.0958988115527792,0.999994989965232,0,0,2.928462709284627,6.865668631741249,GAD1;ACADS;ALDH7A1
KEGG_2021_Human,Glycolysis / Gluconeogenesis,5/67,0.0988407387951208,0.999994989965232,0,0,2.127459234314073,4.923462796124914,ACSS2;ENO2;ALDH7A1;FBP2;GCK
KEGG_2021_Human,Glycosaminoglycan biosynthesis,4/53,0.1288816284099407,0.999994989965232,0,0,2.152011421852692,4.409172069577273,CSGALNACT1;EXT1;EXTL1;HS6ST2
KEGG_2021_Human,Hedgehog signaling pathway,4/56,0.1488699728835097,0.999994989965232,0,0,2.027540360873694,3.8618196686435153,GPR161;BCL2;SPOPL;ARRB2
KEGG_2021_Human,Notch signaling pathway,4/59,0.1699569476962248,0.999994989965232,0,0,1.9166479610924052,3.396702918588762,TLE2;MAML1;DTX1;RFNG
KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.170316514021151,0.999994989965232,0,0,6.578893442622951,11.64527774242234,GCK
KEGG_2021_Human,"Glycine, serine and threonine metabolism",3/40,0.1799904531902733,0.999994989965232,0,0,2.135875601629026,3.662709409488517,BHMT;GLYCTK;ALDH7A1
KEGG_2021_Human,Nicotine addiction,3/40,0.1799904531902733,0.999994989965232,0,0,2.135875601629026,3.662709409488517,GRIN3A;SLC17A6;GABRE
KEGG_2021_Human,Gastric cancer,8/149,0.1814335003828692,0.999994989965232,0,0,1.4967767180239668,2.5547974115578467,TGFB1;WNT5A;TCF7;FGF20;BCL2;CTNNA1;FZD8;TGFBR1
KEGG_2021_Human,Glycerolipid metabolism,4/61,0.1845607507840552,0.999994989965232,0,0,1.8492046302312708,3.124742707520195,DGKD;GLYCTK;PNPLA3;ALDH7A1
KEGG_2021_Human,Histidine metabolism,2/22,0.192060766679892,0.999994989965232,0,0,2.63296853625171,4.344249227051552,CARNMT1;ALDH7A1
KEGG_2021_Human,Cellular senescence,8/156,0.2142709790843519,0.999994989965232,0,0,1.425461323392358,2.195942850863665,HIPK4;TGFB1;MAPKAPK2;CAPN2;NFATC3;ITPR2;FOXO1;TGFBR1
KEGG_2021_Human,Basal transcription factors,3/45,0.2275627215530995,0.999994989965232,0,0,1.8811154598825832,2.7846704814105343,TAF7;GTF2E1;GTF2I
KEGG_2021_Human,Toxoplasmosis,6/112,0.2283090668842242,0.999994989965232,0,0,1.491863694168332,2.2035647458794267,TGFB1;HSPA1L;LAMA4;LAMA3;BCL2;IRGM
KEGG_2021_Human,Pyruvate metabolism,3/47,0.2472193040712061,0.999994989965232,0,0,1.795423412204234,2.509067350513434,ACSS2;PC;ALDH7A1
KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,2/27,0.2602685862660485,0.999994989965232,0,0,2.105827633378933,2.834530664220501,ELOVL2;ELOVL6
KEGG_2021_Human,Adherens junction,4/71,0.2626335347302981,0.999994989965232,0,0,1.5723849886370616,2.102271846789747,TCF7;CTNNA1;TGFBR1;FGFR1
KEGG_2021_Human,Wnt signaling pathway,8/166,0.2646602480357654,0.999994989965232,0,0,1.3345438673068528,1.7740203175308211,TLE2;WNT5A;TCF7;NFATC3;FZD8;PRICKLE1;NOTUM;LGR5
KEGG_2021_Human,Butanoate metabolism,2/28,0.2740149504764603,0.999994989965232,0,0,2.024729032936967,2.62115874931923,GAD1;ACADS
KEGG_2021_Human,Cysteine and methionine metabolism,3/50,0.2771436420985481,0.999994989965232,0,0,1.6805596036141066,2.15652659154757,DNMT1;BHMT;MAT2B
KEGG_2021_Human,Prostate cancer,5/97,0.2831411219746425,0.999994989965232,0,0,1.4314829192546583,1.8062592353247453,TCF7;BCL2;ERG;FOXO1;FGFR1
KEGG_2021_Human,Citrate cycle (TCA cycle),2/30,0.3014522316696605,0.999994989965232,0,0,1.8799101035763144,2.2542823778680403,PC;ACO1
KEGG_2021_Human,Pentose phosphate pathway,2/30,0.3014522316696605,0.999994989965232,0,0,1.8799101035763144,2.2542823778680403,GLYCTK;FBP2
KEGG_2021_Human,Sulfur metabolism,1/10,0.3116581934116328,0.999994989965232,0,0,2.9231936854887675,3.408000171445728,SQOR
KEGG_2021_Human,Galactose metabolism,2/31,0.3151094144332024,0.999994989965232,0,0,1.814991273173263,2.096016087757057,GANC;GCK
KEGG_2021_Human,Protein digestion and absorption,5/103,0.3263089182649161,0.999994989965232,0,0,1.3434206100022426,1.5045111752114946,CPA1;COL22A1;COL8A1;SLC3A2;PRSS3
KEGG_2021_Human,RNA degradation,4/79,0.3288036916184821,0.999994989965232,0,0,1.4040786465477824,1.561748799305228,ENO2;TENT4A;EXOSC1;DCP1B
KEGG_2021_Human,Taurine and hypotaurine metabolism,1/11,0.3368985014385415,0.999994989965232,0,0,2.6307377049180327,2.862173110098555,GAD1
KEGG_2021_Human,SNARE interactions in vesicular transport,2/33,0.3422258353308268,0.999994989965232,0,0,1.6977185472838798,1.8204371522482523,STX6;STX5
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",5/106,0.3481608101105055,0.999994989965232,0,0,1.3033130236100534,1.3751135910577923,MMP17;BCL2;ITPR2;ARRB2;FGFR1
KEGG_2021_Human,Th17 cell differentiation,5/107,0.3554657382860092,0.999994989965232,0,0,1.2904681103210516,1.3347652484294652,TGFB1;IRF4;NFATC3;CD247;TGFBR1
KEGG_2021_Human,Propanoate metabolism,2/34,0.3556584991663665,0.999994989965232,0,0,1.6445793433652531,1.7001402732562327,ACSS2;ACADS
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,2/35,0.3689915105160496,0.999994989965232,0,0,1.5946606972598765,1.589847440287895,PNP;CD38
KEGG_2021_Human,DNA replication,2/36,0.3822141352500399,0.999994989965232,0,0,1.547678442101875,1.4885172944850509,MCM3;MCM2
KEGG_2021_Human,Starch and sucrose metabolism,2/36,0.3822141352500399,0.999994989965232,0,0,1.547678442101875,1.4885172944850509,GANC;GCK
KEGG_2021_Human,Colorectal cancer,4/86,0.3874268850239805,0.999994989965232,0,0,1.2837498745357825,1.217287745230637,TGFB1;TCF7;BCL2;TGFBR1
KEGG_2021_Human,African trypanosomiasis,2/37,0.3953165576620193,0.999994989965232,0,0,1.5033808872386163,1.3952403295447928,LAMA4;APOL1
KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",2/37,0.3953165576620193,0.999994989965232,0,0,1.5033808872386163,1.3952403295447928,GAD1;ADSS1
KEGG_2021_Human,ECM-receptor interaction,4/88,0.4040973557070102,0.999994989965232,0,0,1.253053759226599,1.1353913227812704,LAMA4;LAMA3;FREM1;CD44
KEGG_2021_Human,Basal cell carcinoma,3/63,0.4079624768597801,0.999994989965232,0,0,1.3155479452054797,1.1794940783887489,WNT5A;TCF7;FZD8
KEGG_2021_Human,Lysine degradation,3/63,0.4079624768597801,0.999994989965232,0,0,1.3155479452054797,1.1794940783887489,HYKK;SMYD2;ALDH7A1
KEGG_2021_Human,Hepatocellular carcinoma,7/168,0.419467734207134,0.999994989965232,0,0,1.1442088872918912,0.9940528342613186,TGFB1;SMARCD3;WNT5A;TCF7;MGST1;FZD8;TGFBR1
KEGG_2021_Human,Small cell lung cancer,4/92,0.4371523974759119,0.999994989965232,0,0,1.1958473625140291,0.9895318937484276,LAMA4;LAMA3;BCL2;FHIT
KEGG_2021_Human,Protein processing in endoplasmic reticulum,7/171,0.437469785003231,0.999994989965232,0,0,1.123101861183901,0.9285218114379692,ERLEC1;HSPA1L;CAPN2;BCL2;SEC62;SEC24C;UBE2J1
KEGG_2021_Human,Endocytosis,10/252,0.4443632633531479,0.999994989965232,0,0,1.087354114513677,0.8819669386632976,ACTR3C;RAB31;HSPA1L;GRK5;BIN1;GBF1;ARRB2;EPN1;TGFBR1;RAB7A
KEGG_2021_Human,Salivary secretion,4/93,0.4453384370851364,0.999994989965232,0,0,1.1823492239638724,0.9564268246746506,CD38;ITPR2;ADRA1B;ADRA1A
KEGG_2021_Human,Ferroptosis,2/41,0.4463571749521595,0.999994989965232,0,0,1.3489073625872532,1.0880769786704343,SLC3A2;SLC39A8
KEGG_2021_Human,Breast cancer,6/147,0.4531859806890872,0.999994989965232,0,0,1.1194942784395212,0.886026751791634,WNT5A;TCF7;FGF20;FZD8;ESR1;FGFR1
KEGG_2021_Human,Tryptophan metabolism,2/42,0.4587399471888068,0.999994989965232,0,0,1.3151162790697677,1.0248330212391563,ALDH7A1;INMT
KEGG_2021_Human,Amphetamine addiction,3/69,0.4662997402249224,0.999994989965232,0,0,1.1955790784557907,0.9121391199347032,ARC;GRIN3A;PPP1R1B
KEGG_2021_Human,Primary bile acid biosynthesis,1/17,0.4700708146320679,0.999994989965232,0,0,1.6436987704918034,1.2407820569697736,CYP7B1
KEGG_2021_Human,Selenocompound metabolism,1/17,0.4700708146320679,0.999994989965232,0,0,1.6436987704918034,1.2407820569697736,INMT
KEGG_2021_Human,Fatty acid degradation,2/43,0.4709601333789859,0.999994989965232,0,0,1.28297354108972,0.9660557661655724,ACADS;ALDH7A1
KEGG_2021_Human,Neuroactive ligand-receptor interaction,13/341,0.4822625503993549,0.999994989965232,0,0,1.0425431910569103,0.760291931277183,CHRM2;GRID2;GRP;SCTR;CHRNA9;TACR3;ADRA1B;ADRA1A;GRIN3A;NMUR2;PRSS3;GABRE;NTSR2
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,4/100,0.5014620748871588,0.999994989965232,0,0,1.0957361682670326,0.7563070145195876,TGFB1;BCL2;FOXO1;TGFBR1
KEGG_2021_Human,p53 signaling pathway,3/73,0.5037441651663428,0.999994989965232,0,0,1.1270254403131117,0.7727864097405004,CCNG2;CCNG1;BCL2
KEGG_2021_Human,Proteasome,2/46,0.5066007100437393,0.999994989965232,0,0,1.1953115284168636,0.812850256431602,PSME4;PSMB9
KEGG_2021_Human,Amoebiasis,4/102,0.5170466863640852,0.999994989965232,0,0,1.07326222670138,0.7079474903804459,TGFB1;LAMA4;LAMA3;RAB7A
KEGG_2021_Human,Calcium signaling pathway,9/240,0.5198094646300764,0.999994989965232,0,0,1.0243954940087536,0.6702547484362766,CHRM2;MCOLN3;FGF20;CD38;TACR3;ITPR2;ADRA1B;ADRA1A;FGFR1
KEGG_2021_Human,Steroid biosynthesis,1/20,0.5262757633858585,0.999994989965232,0,0,1.3839516824849007,0.8884000186060488,SOAT1
KEGG_2021_Human,FoxO signaling pathway,5/131,0.5271404812714559,0.999994989965232,0,0,1.0433564451421595,0.6680488182216479,TGFB1;CCNG2;IL7R;FOXO1;TGFBR1
KEGG_2021_Human,"Valine, leucine and isoleucine degradation",2/48,0.5294759083455697,0.999994989965232,0,0,1.143222506393862,0.7269381672414288,ACADS;ALDH7A1
KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.5324001991581665,0.999994989965232,0,0,1.051687242798354,0.6629413793682496,KSR1;MAPKAPK2;NFATC3;ITPR2
KEGG_2021_Human,Cocaine addiction,2/49,0.5406398972938142,0.999994989965232,0,0,1.11884041097884,0.6880889181175833,GRIN3A;PPP1R1B
KEGG_2021_Human,Arginine and proline metabolism,2/50,0.5516189013608362,0.999994989965232,0,0,1.0954742362061105,0.6516952867174274,CKB;ALDH7A1
KEGG_2021_Human,Cholesterol metabolism,2/50,0.5516189013608362,0.999994989965232,0,0,1.0954742362061105,0.6516952867174274,SOAT1;APOH
KEGG_2021_Human,Glucagon signaling pathway,4/107,0.5549662685526653,0.999994989965232,0,0,1.020895760917336,0.6011523703295193,ITPR2;FOXO1;FBP2;GCK
KEGG_2021_Human,Mannose type O-glycan biosynthesis,1/23,0.5765267919621132,0.999994989965232,0,0,1.1950447093889718,0.6581511158680328,FKTN
KEGG_2021_Human,Protein export,1/23,0.5765267919621132,0.999994989965232,0,0,1.1950447093889718,0.6581511158680328,SEC62
KEGG_2021_Human,cGMP-PKG signaling pathway,6/167,0.577508328863059,0.999994989965232,0,0,0.9794014370295692,0.5377231356553275,NFATC3;ITPR2;ADRA1B;ADRA1A;GTF2I;MYH7
KEGG_2021_Human,Ubiquitin mediated proteolysis,5/140,0.5864628128086602,0.999994989965232,0,0,0.9733414733414734,0.5194198015680409,UBE2E3;ERCC8;UBE2L6;MID1;UBE2J1
KEGG_2021_Human,Maturity onset diabetes of the young,1/26,0.6214538422465855,0.999994989965232,0,0,1.0514754098360657,0.5001801641263339,GCK
KEGG_2021_Human,Proteoglycans in cancer,7/205,0.6285702149476615,0.999994989965232,0,0,0.9285903108217156,0.4311514818622021,TGFB1;WNT5A;FZD8;ITPR2;ESR1;CD44;FGFR1
KEGG_2021_Human,Endometrial cancer,2/58,0.632685830020854,0.999994989965232,0,0,0.9385870627320696,0.42966760492168,TCF7;CTNNA1
KEGG_2021_Human,Collecting duct acid secretion,1/27,0.6353455712313132,0.999994989965232,0,0,1.010981504833964,0.4585672807362063,ATP6V0D2
KEGG_2021_Human,Bile secretion,3/90,0.6457255725129256,0.999994989965232,0,0,0.9059990552668872,0.3962664790745148,SCTR;SLC51A;SLC22A8
KEGG_2021_Human,Phototransduction,1/28,0.6487281750397981,0.999994989965232,0,0,0.9734871483505364,0.4212682757876207,PDE6B
KEGG_2021_Human,Long-term depression,2/60,0.651072809759388,0.999994989965232,0,0,0.906127647530544,0.3888500007415678,GRID2;ITPR2
KEGG_2021_Human,Thyroid hormone signaling pathway,4/121,0.6519219415366296,0.999994989965232,0,0,0.8980807334716799,0.3842262805586374,HDAC3;ESR1;FOXO1;MYH7
KEGG_2021_Human,Morphine addiction,3/91,0.6531162465251998,0.999994989965232,0,0,0.8956569115815691,0.3815499754294649,GRK5;ARRB2;GABRE
KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.6603959205667445,0.999994989965232,0,0,0.8855471756195167,0.3674274653706584,MAML1;NFATC3;CD247
KEGG_2021_Human,Cell cycle,4/124,0.6707587090362332,0.999994989965232,0,0,0.8754915409236397,0.3496238748230248,TGFB1;MCM3;BUB1;MCM2
KEGG_2021_Human,Human papillomavirus infection,11/331,0.6722770293554923,0.999994989965232,0,0,0.9020818905817176,0.3582029866679933,MAML1;LAMA4;WNT5A;TCF7;LAMA3;FZD8;SCRIB;RFNG;ATP6V0D2;LLGL1;FOXO1
KEGG_2021_Human,Ascorbate and aldarate metabolism,1/30,0.674039864163672,0.999994989965232,0,0,0.906255888449218,0.3574871572021389,ALDH7A1
KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.6746219713508076,0.999994989965232,0,0,0.8659942796929099,0.3408577623900684,GREM2;TGFB1;TGFBR1
KEGG_2021_Human,GnRH secretion,2/64,0.6856380252222957,0.999994989965232,0,0,0.8474912845858523,0.3198478300908996,ITPR2;ARRB2
KEGG_2021_Human,Circadian rhythm,1/31,0.6860042001590217,0.999994989965232,0,0,0.8760018214936248,0.3301401455176108,PER2
KEGG_2021_Human,Fc gamma R-mediated phagocytosis,3/97,0.6951290463232629,0.999994989965232,0,0,0.8382250072865054,0.3048270389955878,ACTR3C;MYO10;BIN1
KEGG_2021_Human,Phosphatidylinositol signaling system,3/97,0.6951290463232629,0.999994989965232,0,0,0.8382250072865054,0.3048270389955878,DGKD;ITPR2;PI4KB
KEGG_2021_Human,Purine metabolism,4/129,0.700565598806041,0.999994989965232,0,0,0.8402524005486969,0.2990183294900854,PNP;ADSS1;PDE6B;FHIT
KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.7082486446334678,0.999994989965232,0,0,0.8206763698630137,0.2831005648292746,CD38;IL7R;CD44
KEGG_2021_Human,Fructose and mannose metabolism,1/33,0.7086332024611642,0.999994989965232,0,0,0.821166325136612,0.2828238320793663,FBP2
KEGG_2021_Human,Acute myeloid leukemia,2/67,0.7096785189509085,0.999994989965232,0,0,0.8082500263074819,0.2771838517937381,PER2;TCF7
KEGG_2021_Human,Mitophagy,2/68,0.7173432445977393,0.999994989965232,0,0,0.7959623595738506,0.2644193562171131,PINK1;RAB7A
KEGG_2021_Human,Melanogenesis,3/101,0.720930677074263,0.999994989965232,0,0,0.8038440033547666,0.2630276408556271,WNT5A;TCF7;FZD8
KEGG_2021_Human,Renal cell carcinoma,2/69,0.7248370718238266,0.999994989965232,0,0,0.784041488862119,0.2523111197382421,EGLN3;TGFB1
KEGG_2021_Human,Renin secretion,2/69,0.7248370718238266,0.999994989965232,0,0,0.784041488862119,0.2523111197382421,CLCA2;ITPR2
KEGG_2021_Human,Chagas disease,3/102,0.7271089729391111,0.999994989965232,0,0,0.7956828559568285,0.2535673521485941,TGFB1;CD247;TGFBR1
KEGG_2021_Human,Central carbon metabolism in cancer,2/70,0.7321622125981886,0.999994989965232,0,0,0.7724712319948499,0.2408203689506661,GCK;FGFR1
KEGG_2021_Human,Prolactin signaling pathway,2/70,0.7321622125981886,0.999994989965232,0,0,0.7724712319948499,0.2408203689506661,ESR1;GCK
KEGG_2021_Human,Tyrosine metabolism,1/36,0.7395596885927105,0.999994989965232,0,0,0.7506635441061671,0.22647540541446,DBH
KEGG_2021_Human,Estrogen signaling pathway,4/137,0.7441188006148607,0.999994989965232,0,0,0.7893808595562981,0.2333051273409145,HSPA1L;BCL2;ITPR2;ESR1
KEGG_2021_Human,Insulin signaling pathway,4/137,0.7441188006148607,0.999994989965232,0,0,0.7893808595562981,0.2333051273409145,FOXO1;FBP2;SH2B2;GCK
KEGG_2021_Human,Melanoma,2/72,0.7463156122854264,0.999994989965232,0,0,0.7503224545632207,0.2195493739740047,FGF20;FGFR1
KEGG_2021_Human,Thyroid cancer,1/37,0.7491219848220599,0.999994989965232,0,0,0.7297738312082575,0.2107976853210952,TCF7
KEGG_2021_Human,Pathways in cancer,17/531,0.7502218433099025,0.999994989965232,0,0,0.8662505706149599,0.2489485681130128,EGLN3;TGFB1;DAPK2;LAMA4;WNT5A;TCF7;LAMA3;MGST1;FZD8;ESR1;FOXO1;TGFBR1;BCL2;CTNNA1;FGF20;IL7R;FGFR1
KEGG_2021_Human,Inositol phosphate metabolism,2/73,0.7531486017820482,0.999994989965232,0,0,0.7397159977649757,0.2097041034356688,PLCH1;PI4KB
KEGG_2021_Human,MAPK signaling pathway,9/294,0.7542436174865081,0.999994989965232,0,0,0.8279441698168072,0.2335132602640801,PPP5C;TGFB1;HSPA1L;MAPKAPK2;NFATC3;FGF20;ARRB2;TGFBR1;FGFR1
KEGG_2021_Human,Primary immunodeficiency,1/38,0.7583336518048772,0.999994989965232,0,0,0.7100132919805051,0.1964122665597035,IL7R
KEGG_2021_Human,Thyroid hormone synthesis,2/75,0.7663393367983544,0.999994989965232,0,0,0.7193748477409441,0.1914473785103785,DUOX1;ITPR2
KEGG_2021_Human,Various types of N-glycan biosynthesis,1/39,0.7672075292882747,0.999994989965232,0,0,0.6912927811331607,0.1831911639584684,MGAT4C
KEGG_2021_Human,HIF-1 signaling pathway,3/109,0.7673862897704095,0.999994989965232,0,0,0.7428663737399845,0.1966849910386193,EGLN3;BCL2;ENO2
KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.7727020657455442,0.999994989965232,0,0,0.7096165933375236,0.1829829628446552,TGFB1;TGFBR1
KEGG_2021_Human,Gastric acid secretion,2/76,0.7727020657455442,0.999994989965232,0,0,0.7096165933375236,0.1829829628446552,ITPR2;SLC26A7
KEGG_2021_Human,Pancreatic cancer,2/76,0.7727020657455442,0.999994989965232,0,0,0.7096165933375236,0.1829829628446552,TGFB1;TGFBR1
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,4/143,0.7734952911623828,0.999994989965232,0,0,0.7550700180596264,0.1939289341378498,WNT5A;TCF7;FZD8;FGFR1
KEGG_2021_Human,Chemical carcinogenesis,7/239,0.7771003763235842,0.999994989965232,0,0,0.791090766600171,0.1995018202712186,EPHX2;MGST1;CHRNA9;FGF20;BCL2;ARRB2;ESR1
KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.778913073243481,0.999994989965232,0,0,0.7001185590515275,0.1749287015407725,TCF7;CTNNA1
KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.778913073243481,0.999994989965232,0,0,0.7001185590515275,0.1749287015407725,ACTR3C;CTNNA1
KEGG_2021_Human,Bladder cancer,1/41,0.7839909447842559,0.999994989965232,0,0,0.6566598360655738,0.1598032987783759,DAPK2
KEGG_2021_Human,Homologous recombination,1/41,0.7839909447842559,0.999994989965232,0,0,0.6566598360655738,0.1598032987783759,BRCC3
KEGG_2021_Human,Synaptic vesicle cycle,2/78,0.7849749159818957,0.999994989965232,0,0,0.6908704730362157,0.167262170535231,SLC17A6;ATP6V0D2
KEGG_2021_Human,Cholinergic synapse,3/113,0.7881447334863569,0.999994989965232,0,0,0.7157036114570361,0.1703900881139871,CHRM2;BCL2;ITPR2
KEGG_2021_Human,Glutamatergic synapse,3/114,0.7930878080541186,0.999994989965232,0,0,0.7092188078489449,0.1644120505102834,GRIN3A;ITPR2;SLC17A6
KEGG_2021_Human,Tuberculosis,5/180,0.7934306062709134,0.999994989965232,0,0,0.7492935635792779,0.173378434910811,TGFB1;KSR1;BCL2;ATP6V0D2;RAB7A
KEGG_2021_Human,Type I diabetes mellitus,1/43,0.7995658634555878,0.999994989965232,0,0,0.6253252667187094,0.1398767385399546,GAD1
KEGG_2021_Human,Axon guidance,5/182,0.8012131823204651,0.999994989965232,0,0,0.7407493636307195,0.164170964486943,ROBO2;EFNB1;WNT5A;NFATC3;SRGAP2
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,4/150,0.8043396674557696,0.999994989965232,0,0,0.7186049570625928,0.1564644637241099,BCL2;ADRA1B;ADRA1A;MYH7
KEGG_2021_Human,Vasopressin-regulated water reabsorption,1/44,0.8069275444748374,0.999994989965232,0,0,0.6107510484178421,0.1310191690671079,AQP3
KEGG_2021_Human,Salmonella infection,7/249,0.8112155395724326,0.999994989965232,0,0,0.7580026409853607,0.1585904420095835,ACTR3C;SNX18;TCF7;BCL2;ACBD3;VPS16;RAB7A
KEGG_2021_Human,ABC transporters,1/45,0.8140191932120633,0.999994989965232,0,0,0.5968392945851962,0.1228124180530213,ABCA9
KEGG_2021_Human,Glycosphingolipid biosynthesis,1/45,0.8140191932120633,0.999994989965232,0,0,0.5968392945851962,0.1228124180530213,ST6GALNAC3
KEGG_2021_Human,Neurotrophin signaling pathway,3/119,0.8163797334524803,0.999994989965232,0,0,0.6784718941898914,0.137645441901856,MAPKAPK2;BCL2;SH2B2
KEGG_2021_Human,Oxytocin signaling pathway,4/154,0.8203796245872735,0.999994989965232,0,0,0.6992958390489254,0.1384522468479916,TRPM2;NFATC3;ITPR2;CD38
KEGG_2021_Human,AMPK signaling pathway,3/120,0.8207616227312468,0.999994989965232,0,0,0.6726378644186863,0.132861154002703,ADRA1A;FOXO1;FBP2
KEGG_2021_Human,Type II diabetes mellitus,1/46,0.8208507016716189,0.999994989965232,0,0,0.5835458409228901,0.1152001393155428,GCK
KEGG_2021_Human,Cushing syndrome,4/155,0.8242160831455507,0.999994989965232,0,0,0.6946284032376747,0.1342873318709973,WNT5A;TCF7;ITPR2;FZD8
KEGG_2021_Human,Nucleotide excision repair,1/47,0.8274315999356233,0.999994989965232,0,0,0.5708303635067712,0.1081317300769281,ERCC8
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.8337710692721777,0.999994989965232,0,0,0.5586559702360191,0.1015616506967797,GCK
KEGG_2021_Human,Intestinal immune network for IgA production,1/48,0.8337710692721777,0.999994989965232,0,0,0.5586559702360191,0.1015616506967797,TGFB1
KEGG_2021_Human,Transcriptional misregulation in cancer,5/192,0.8366999162253571,0.999994989965232,0,0,0.7007698184168772,0.1249401078323111,PER2;ERG;CDK14;FOXO1;MLF1
KEGG_2021_Human,Ether lipid metabolism,1/49,0.8398779552837128,0.999994989965232,0,0,0.5469888433515483,0.095448836078607,ENPP2
KEGG_2021_Human,Sphingolipid metabolism,1/49,0.8398779552837128,0.999994989965232,0,0,0.5469888433515483,0.095448836078607,PSAP
KEGG_2021_Human,GABAergic synapse,2/89,0.8425497280125346,0.999994989965232,0,0,0.6031731056496376,0.1033371811815686,GAD1;GABRE
KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/89,0.8425497280125346,0.999994989965232,0,0,0.6031731056496376,0.1033371811815686,NFATC3;CD247
KEGG_2021_Human,Malaria,1/50,0.845760779673637,0.999994989965232,0,0,0.5357979257276682,0.0897561857533202,TGFB1
KEGG_2021_Human,N-Glycan biosynthesis,1/50,0.845760779673637,0.999994989965232,0,0,0.5357979257276682,0.0897561857533202,MGAT4C
KEGG_2021_Human,Vibrio cholerae infection,1/50,0.845760779673637,0.999994989965232,0,0,0.5357979257276682,0.0897561857533202,ATP6V0D2
KEGG_2021_Human,Hypertrophic cardiomyopathy,2/90,0.8470229946934535,0.999994989965232,0,0,0.5962877751523442,0.0990001306056839,TGFB1;MYH7
KEGG_2021_Human,Hepatitis B,4/162,0.8492089929383408,0.999994989965232,0,0,0.6636106336059454,0.1084671310636869,TGFB1;NFATC3;BCL2;TGFBR1
KEGG_2021_Human,Lysosome,3/128,0.8527035857634224,0.999994989965232,0,0,0.6293260273972603,0.1002788784643389,PSAP;PPT1;ATP6V0D2
KEGG_2021_Human,Oocyte meiosis,3/129,0.8563259110695379,0.999994989965232,0,0,0.6242987606001305,0.0968313835919609,CPEB1;ITPR2;BUB1
KEGG_2021_Human,Relaxin signaling pathway,3/129,0.8563259110695379,0.999994989965232,0,0,0.6242987606001305,0.0968313835919609,TGFB1;ARRB2;TGFBR1
KEGG_2021_Human,Rheumatoid arthritis,2/93,0.8597577090034436,0.999994989965232,0,0,0.576539739330437,0.0871178431017558,TGFB1;ATP6V0D2
KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,1/53,0.8621454918528928,0.999994989965232,0,0,0.5048076923076923,0.074878750208764,ESR1
KEGG_2021_Human,Dopaminergic synapse,3/132,0.8667291702875184,0.999994989965232,0,0,0.6096846129340554,0.0872024138635191,PPP1R1B;ITPR2;ARRB2
KEGG_2021_Human,Viral carcinogenesis,5/203,0.869567393266209,0.999994989965232,0,0,0.6614565989565989,0.092444803935275,HDAC3;MAPKAPK2;SCRIB;ATP6V0D2;GTF2E1
KEGG_2021_Human,Vascular smooth muscle contraction,3/133,0.8700465367994474,0.999994989965232,0,0,0.6049631190727082,0.0842160556634993,ITPR2;ADRA1B;ADRA1A
KEGG_2021_Human,Tight junction,4/169,0.8711303296360943,0.999994989965232,0,0,0.6352246747308475,0.0876379344736608,ACTR3C;SCRIB;AMOTL1;LLGL1
KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.8715157779887345,0.999994989965232,0,0,0.5580522164333324,0.0767440717302136,TGFB1;MYH7
KEGG_2021_Human,Pyrimidine metabolism,1/56,0.8767917650150074,0.999994989965232,0,0,0.4771982116244411,0.0627447671033642,PNP
KEGG_2021_Human,Choline metabolism in cancer,2/98,0.8788434426044186,0.999994989965232,0,0,0.5463691290469677,0.0705627565702315,SLC44A5;DGKD
KEGG_2021_Human,Glutathione metabolism,1/57,0.8813199600873997,0.999994989965232,0,0,0.4686524199843872,0.0592069882142268,MGST1
KEGG_2021_Human,Legionellosis,1/57,0.8813199600873997,0.999994989965232,0,0,0.4686524199843872,0.0592069882142268,HSPA1L
KEGG_2021_Human,Autophagy,3/137,0.8825973205775896,0.999994989965232,0,0,0.5867818442036393,0.073280965301921,DAPK2;BCL2;RAB7A
KEGG_2021_Human,Progesterone-mediated oocyte maturation,2/100,0.8857836328492773,0.999994989965232,0,0,0.5351629023702504,0.0649059294477632,CPEB1;BUB1
KEGG_2021_Human,VEGF signaling pathway,1/59,0.8898838241550452,0.999994989965232,0,0,0.4524448841153194,0.0527841925843204,MAPKAPK2
KEGG_2021_Human,Shigellosis,6/246,0.8912160287322182,0.999994989965232,0,0,0.6542984869325997,0.0753545258335929,ACTR3C;CAPN2;BCL2;ITPR2;CD44;FOXO1
KEGG_2021_Human,Longevity regulating pathway,2/102,0.8923540766625815,0.999994989965232,0,0,0.524404924760602,0.0597256715978905,HSPA1L;FOXO1
KEGG_2021_Human,Mineral absorption,1/60,0.8939314550883393,0.999994989965232,0,0,0.4447531721774567,0.0498684737538158,SLC26A3
KEGG_2021_Human,Viral myocarditis,1/60,0.8939314550883393,0.999994989965232,0,0,0.4447531721774567,0.0498684737538158,MYH7
KEGG_2021_Human,Apoptosis,3/142,0.8967607698606191,0.999994989965232,0,0,0.5655267566768503,0.0616232749585108,CAPN2;BCL2;ITPR2
KEGG_2021_Human,Arachidonic acid metabolism,1/61,0.8978304963553234,0.999994989965232,0,0,0.4373178506375227,0.047131487623256,EPHX2
KEGG_2021_Human,Steroid hormone biosynthesis,1/61,0.8978304963553234,0.999994989965232,0,0,0.4373178506375227,0.047131487623256,CYP7B1
KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.8985719610822158,0.999994989965232,0,0,0.5140688286258416,0.0549788827793525,EDARADD;BCL2
KEGG_2021_Human,T cell receptor signaling pathway,2/104,0.8985719610822158,0.999994989965232,0,0,0.5140688286258416,0.0549788827793525,NFATC3;CD247
KEGG_2021_Human,NOD-like receptor signaling pathway,4/181,0.9023445569034062,0.999994989965232,0,0,0.591786597227066,0.0608113040973706,TRPM2;BCL2;ITPR2;BRCC3
KEGG_2021_Human,Ribosome biogenesis in eukaryotes,2/108,0.9100160152634484,0.999994989965232,0,0,0.4945667604470485,0.0466342233235594,TCOF1;REXO5
KEGG_2021_Human,Retrograde endocannabinoid signaling,3/148,0.9117168495090254,0.999994989965232,0,0,0.5419555975436939,0.0500906846229884,ITPR2;SLC17A6;GABRE
KEGG_2021_Human,Cortisol synthesis and secretion,1/65,0.9120467684301716,0.999994989965232,0,0,0.4099001024590163,0.0377370467420574,ITPR2
KEGG_2021_Human,Inflammatory bowel disease,1/65,0.9120467684301716,0.999994989965232,0,0,0.4099001024590163,0.0377370467420574,TGFB1
KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,1/66,0.915280693844738,0.999994989965232,0,0,0.403572929802438,0.0357260884025838,NARS1
KEGG_2021_Human,Long-term potentiation,1/67,0.9183958651756462,0.999994989965232,0,0,0.3974374896506044,0.0338325640601598,ITPR2
KEGG_2021_Human,mTOR signaling pathway,3/154,0.9246788381518232,0.999994989965232,0,0,0.5202576431098612,0.0407407536770104,WNT5A;FZD8;SLC3A2
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,4/193,0.926685215614686,0.999994989965232,0,0,0.5538644660729709,0.0421719850153925,MAPKAPK2;TCF7;NFATC3;ITPR2
KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,1/70,0.927071613530981,0.999994989965232,0,0,0.3800982022649877,0.0287827324058823,ATP6V0D2
KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.927071613530981,0.999994989965232,0,0,0.3800982022649877,0.0287827324058823,TBKBP1
KEGG_2021_Human,Non-small cell lung cancer,1/72,0.932337375847902,0.999994989965232,0,0,0.3693527283922111,0.0258770510647621,FHIT
KEGG_2021_Human,Pathogenic Escherichia coli infection,4/197,0.9334947114419396,0.999994989965232,0,0,0.5422716902279366,0.0373191275901997,ACTR3C;MYO10;NLRP4;SEC24C
KEGG_2021_Human,Focal adhesion,4/201,0.9397266263023684,0.999994989965232,0,0,0.531149687006051,0.0330195943736876,LAMA4;LAMA3;CAPN2;BCL2
KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,1/76,0.9417570208864798,0.999994989965232,0,0,0.3495810564663024,0.0209776520970499,MGST1
KEGG_2021_Human,Leishmaniasis,1/77,0.9438996917430372,0.999994989965232,0,0,0.3449633304572908,0.0199165880142202,TGFB1
KEGG_2021_Human,Antigen processing and presentation,1/78,0.9459636373694358,0.999994989965232,0,0,0.3404655453835781,0.0189132522299801,HSPA1L
KEGG_2021_Human,Osteoclast differentiation,2/127,0.9496368356031804,0.999994989965232,0,0,0.4189767441860465,0.0216508938255374,TGFB1;TGFBR1
KEGG_2021_Human,PI3K-Akt signaling pathway,8/354,0.9498131873794884,0.999994989965232,0,0,0.6034203707394857,0.031070089900763,CHRM2;LAMA4;LAMA3;FGF20;BCL2;THEM4;IL7R;FGFR1
KEGG_2021_Human,B cell receptor signaling pathway,1/81,0.951711483536331,0.999994989965232,0,0,0.3276468579234973,0.0162163418069502,NFATC3
KEGG_2021_Human,Peroxisome,1/82,0.9534883752619068,0.999994989965232,0,0,0.3235849693044593,0.0154117196947964,EPHX2
KEGG_2021_Human,Human immunodeficiency virus 1 infection,4/212,0.954220128283086,0.999994989965232,0,0,0.502769863880975,0.0235602441492392,NFATC3;BCL2;ITPR2;CD247
KEGG_2021_Human,Complement and coagulation cascades,1/85,0.9584367350788386,0.999994989965232,0,0,0.311979573250065,0.0132440703521852,F8
KEGG_2021_Human,ErbB signaling pathway,1/85,0.9584367350788386,0.999994989965232,0,0,0.311979573250065,0.0132440703521852,NRG2
KEGG_2021_Human,Insulin secretion,1/86,0.9599664493786504,0.999994989965232,0,0,0.3082931533269045,0.0125959160069931,GCK
KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,0.9607010509144592,0.999994989965232,0,0,0.4885196723202953,0.0195857305376041,CHRM2;ACTR3C;FGF20;FGFR1
KEGG_2021_Human,Cardiac muscle contraction,1/87,0.9614399339948068,0.999994989965232,0,0,0.3046924640996314,0.0119814787581961,MYH7
KEGG_2021_Human,Gap junction,1/88,0.9628592529919804,0.999994989965232,0,0,0.3011745493373531,0.0113988641612494,ITPR2
KEGG_2021_Human,Apelin signaling pathway,2/137,0.9631416721290376,0.999994989965232,0,0,0.3877387647565486,0.0145614372634315,ITPR2;TGFBR1
KEGG_2021_Human,Yersinia infection,2/137,0.9631416721290376,0.999994989965232,0,0,0.3877387647565486,0.0145614372634315,ACTR3C;NFATC3
KEGG_2021_Human,Fluid shear stress and atherosclerosis,2/139,0.9653894561844916,0.999994989965232,0,0,0.3820384035467862,0.0134567975275295,MGST1;BCL2
KEGG_2021_Human,Measles,2/139,0.9653894561844916,0.999994989965232,0,0,0.3820384035467862,0.0134567975275295,HSPA1L;BCL2
KEGG_2021_Human,Alcoholism,3/186,0.968770186588324,0.999994989965232,0,0,0.4285650123512239,0.0135974510398119,GRIN3A;HDAC3;PPP1R1B
KEGG_2021_Human,GnRH signaling pathway,1/93,0.969210465399728,0.999994989965232,0,0,0.284732121644096,0.0089045677627272,ITPR2
KEGG_2021_Human,Spinocerebellar ataxia,2/143,0.969496108197038,0.999994989965232,0,0,0.3711228182514965,0.0114969464444048,GRIN3A;ITPR2
KEGG_2021_Human,Circadian entrainment,1/97,0.9735009062982998,0.999994989965232,0,0,0.2728113615664845,0.0073267646614989,PER2
KEGG_2021_Human,Aldosterone synthesis and secretion,1/98,0.9744767452324956,0.999994989965232,0,0,0.2699847895893189,0.0069803551126727,ITPR2
KEGG_2021_Human,Glycerophospholipid metabolism,1/98,0.9744767452324956,0.999994989965232,0,0,0.2699847895893189,0.0069803551126727,DGKD
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,1/98,0.9744767452324956,0.999994989965232,0,0,0.2699847895893189,0.0069803551126727,ITPR2
KEGG_2021_Human,mRNA surveillance pathway,1/98,0.9744767452324956,0.999994989965232,0,0,0.2699847895893189,0.0069803551126727,CPSF1
KEGG_2021_Human,Phagosome,2/152,0.9770902823160807,0.999994989965232,0,0,0.3486912904696762,0.0080813472858898,ATP6V0D2;RAB7A
KEGG_2021_Human,Epstein-Barr virus infection,3/202,0.9802484062797704,0.999994989965232,0,0,0.3937771047015901,0.0078555632776381,BCL2;CD247;CD44
KEGG_2021_Human,Pathways of neurodegeneration,10/475,0.9816383005331176,0.999994989965232,0,0,0.5592587635152219,0.010364389142007,DNAH11;PINK1;HIP1;WNT5A;BCL2;CAPN2;FZD8;ITPR2;UBE2L6;UBE2J1
KEGG_2021_Human,Necroptosis,2/159,0.9816979656000716,0.999994989965232,0,0,0.3330225587494663,0.0061514557028219,CAPN2;BCL2
KEGG_2021_Human,Drug metabolism,1/108,0.9824634394701774,0.999994989965232,0,0,0.2446248914764312,0.0043279397028494,MGST1
KEGG_2021_Human,Insulin resistance,1/108,0.9824634394701774,0.999994989965232,0,0,0.2446248914764312,0.0043279397028494,FOXO1
KEGG_2021_Human,Parkinson disease,4/249,0.9826042741140416,0.999994989965232,0,0,0.4260127096105932,0.0074760158669941,PINK1;ITPR2;UBE2L6;UBE2J1
KEGG_2021_Human,JAK-STAT signaling pathway,2/162,0.983384977203372,0.999994989965232,0,0,0.3267270861833105,0.0054741818033587,BCL2;IL7R
KEGG_2021_Human,Rap1 signaling pathway,3/210,0.984351776199942,0.999994989965232,0,0,0.3783998411753028,0.0059681032532746,FGF20;SKAP1;FGFR1
KEGG_2021_Human,Serotonergic synapse,1/113,0.985464813165352,0.999994989965232,0,0,0.233643149882904,0.0034209697245245,ITPR2
KEGG_2021_Human,Leukocyte transendothelial migration,1/114,0.9860004627367024,0.999994989965232,0,0,0.2315634218289085,0.0032646864991149,CTNNA1
KEGG_2021_Human,Lipid and atherosclerosis,3/215,0.9864874554412312,0.999994989965232,0,0,0.3693783923494443,0.005025271069572,HSPA1L;NFATC3;BCL2
KEGG_2021_Human,cAMP signaling pathway,3/216,0.986879646004827,0.999994989965232,0,0,0.3676249276480802,0.0048552908670484,CHRM2;GRIN3A;PPP1R1B
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,3/219,0.987991717115912,0.999994989965232,0,0,0.3624619482496194,0.0043788900219518,TGFB1;NFATC3;TGFBR1
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",1/119,0.9883970517034496,0.999994989965232,0,0,0.2216935259794387,0.0025873380917555,ITPR2
KEGG_2021_Human,Sphingolipid signaling pathway,1/119,0.9883970517034496,0.999994989965232,0,0,0.2216935259794387,0.0025873380917555,BCL2
KEGG_2021_Human,Herpes simplex virus 1 infection,10/498,0.9885867344310688,0.999994989965232,0,0,0.5322483731265447,0.0061096241149387,ZNF561;ZNF808;ZNF284;ZNF195;ZNF616;BCL2;ZNF623;ZNF347;ZNF212;ZNF33B
KEGG_2021_Human,Platelet activation,1/124,0.9903837485962744,0.999994989965232,0,0,0.2126260606868363,0.0020545601470793,ITPR2
KEGG_2021_Human,Ras signaling pathway,3/232,0.9918471601746812,0.999994989965232,0,0,0.3416522103248191,0.002796852447184,KSR1;FGF20;FGFR1
KEGG_2021_Human,Thermogenesis,3/232,0.9918471601746812,0.999994989965232,0,0,0.3416522103248191,0.002796852447184,SMARCD3;NDUFAF6;FGFR1
KEGG_2021_Human,RNA transport,2/186,0.9924040966527504,0.999994989965232,0,0,0.2837536430143341,0.0021635929106534,NUP210;SMN2
KEGG_2021_Human,Natural killer cell mediated cytotoxicity,1/131,0.9926075078359284,0.999994989965232,0,0,0.2011034047919293,0.0014921776205057,CD247
KEGG_2021_Human,Oxidative phosphorylation,1/133,0.9931427102269416,0.999994989965232,0,0,0.1980356847160125,0.0013626655297449,ATP6V0D2
KEGG_2021_Human,Chemokine signaling pathway,2/192,0.9937681428190376,0.999994989965232,0,0,0.2747066023471812,0.0017172888369918,GRK5;ARRB2
KEGG_2021_Human,Diabetic cardiomyopathy,2/203,0.9956735944870704,0.999994989965232,0,0,0.2595231775459229,0.0011252383838125,TGFB1;TGFBR1
KEGG_2021_Human,Cell adhesion molecules,1/148,0.996097910179296,0.999994989965232,0,0,0.1776885617635032,0.0006947130276464313,NLGN1
KEGG_2021_Human,Phospholipase D signaling pathway,1/148,0.996097910179296,0.999994989965232,0,0,0.1776885617635032,0.0006947130276464313,DGKD
KEGG_2021_Human,Spliceosome,1/150,0.9963805515903926,0.999994989965232,0,0,0.1752851432134081,0.0006355864641687244,HSPA1L
KEGG_2021_Human,MicroRNAs in cancer,4/310,0.9968464073453716,0.999994989965232,0,0,0.3399947999318611,0.001073899315587,DNMT1;CCNG1;BCL2;CD44
KEGG_2021_Human,Non-alcoholic fatty liver disease,1/155,0.9970008393847408,0.999994989965232,0,0,0.1695497125824994,0.0005092708952246953,TGFB1
KEGG_2021_Human,Ribosome,1/158,0.9973207623057188,0.999994989965232,0,0,0.1662838049493578,0.0004461117250625951,RPL37A
KEGG_2021_Human,Amyotrophic lateral sclerosis,5/364,0.9975835849880604,0.999994989965232,0,0,0.3617343659126389,0.0008751581511299565,DNAH11;PINK1;NUP210;BCL2;NRG2
KEGG_2021_Human,Prion disease,3/273,0.9976712464174003,0.999994989965232,0,0,0.2891476407914764,0.0006741388610523991,GRIN3A;HSPA1L;ITPR2
KEGG_2021_Human,Human cytomegalovirus infection,2/225,0.997929443062646,0.999994989965232,0,0,0.2336500769877249,0.00048428733326832013,NFATC3;ITPR2
KEGG_2021_Human,Influenza A,1/172,0.9984173146342356,0.999994989965232,0,0,0.1525580800818074,0.00024164271344847356,PRSS3
KEGG_2021_Human,Cytokine-cytokine receptor interaction,3/295,0.9988303933116944,0.999994989965232,0,0,0.2670529179958716,0.0003125296830719766,TGFB1;IL7R;TGFBR1
KEGG_2021_Human,Neutrophil extracellular trap formation,1/189,0.99916457688841,0.999994989965232,0,0,0.1386394023950703,0.0001158709683222898,HDAC3
KEGG_2021_Human,Alzheimer disease,4/369,0.9994498625979128,0.999994989965232,0,0,0.2841498017550782,0.00015636444865162292,WNT5A;CAPN2;FZD8;ITPR2
KEGG_2021_Human,Coronavirus disease,1/232,0.9998326129050268,0.999994989965232,0,0,0.1125777683154732,1.8845642899621933e-05,RPL37A
KEGG_2021_Human,Huntington disease,2/306,0.9998685740444276,0.999994989965232,0,0,0.1706656346749226,2.24313681847854e-05,DNAH11;HIP1
KEGG_2021_Human,Olfactory transduction,2/440,0.999994989965232,0.999994989965232,0,0,0.1176158261966781,5.892608546281165e-07,ARRB2;OR13A1
